💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
Endocrine Med 2010 Step2
1. Endocrine Disease
J
IRA
SIR
RAJ
IRI
JS
IRA
Apiradee Sriwijitkamol, MD
SIR
Division of Endocrinology and Metabolism
Department of Medicine
Faculty of Medicine Siriraj Hospital
2. Topic
J
IRA
Thyroid disease
SIR
DM
RAJ
IRI
JS
IRA
SIR
3. Topic
J
IRA
Thyroid disease
SIR
DM
RAJ
IRI
JS
IRA
SIR
5. + Hypothalamus
J
IRA
-
TRH
SIR
Pituitary
RAJ
TSH
IRI
JS
Thyroid
IRA
SIR
T4-TBG T4 T3 T3-TBG
6. Case 1
J
IRA
• 66 year old lady
SIR
• Presents with:
• Depression
RAJ
• Myalgia
IRI
• Weight gain
• On Examination:
JS
• Slow relaxing reflexes
IRA
• Sinus bradycardia
SIR
• BMI 32
• Swelling on the anterior aspect of the neck
8. Case 1
J
IRA
• What is the diagnosis?
SIR
RAJ
IRI
JS
IRA
SIR
9. Case 2
J
IRA
• 36 year old lady
SIR
• Presents with:
•
RAJ
Weight loss
• Dyspnea on exertion For 6 months
•
IRI
Palpitation
JS
• On Examination:
IRA
• Diffuse thyroid enlargement
•
SIR
Sinus tachycardia, warm moist skin
• Exophthalmos
11. Case 2
J
IRA
• What is the diagnosis?
SIR
RAJ
IRI
JS
IRA
SIR
12. Case 3
J
IRA
• 36 year old lady
SIR
• Presents with:
•
RAJ
Weight loss
• Dyspnea on exertion For 2 months
•
IRI
Palpitation
JS
• On Examination:
IRA
• Thyroid nodule 2 cm at right lobe
•
SIR
Sinus tachycardia, warm moist skin
• No exophthalmos, no pretibial myxedmea
14. Case 3
J
IRA
• What is the diagnosis?
SIR
RAJ
IRI
JS
IRA
SIR
15. HYPOTHYROIDISM
J
IRA
Signs & Symptoms :-
SIR
Tiredness / malaise Change in appearance
RAJ
Mental slowness Anaemia
Reduced appetite Heart failure
IRI
Constipation
JS Hypertension
Sensitivity to drugs Bradycardia
Cold intolerance Dyspnoea
IRA
/ Hypothermia
SIR
16. HYPOTHYROIDISM
J
Aetiology
IRA
SIR
Primary (90%) Secondary (<10%) Tertiary (Rare)
Thyroid Tissue Dysfunction of Dysfunction of
RAJ
Loss or Atrophy Pituitary Gland Hypothalamus
Tumour or
IRI
Autoimmune Decreased TRH
surgery
Post Surgery Production
JS
Post Irradiation Decreased TSH
Infiltration Production
IRA
Decreased Hormone
SIR
Synthesis
Decreased Thyroxin
Production
17. HYPOTHYROIDISM
J
IRA
DIAGNOSIS
SIR
Serum T4 or fT4
RAJ
Below Normal
IRI
Primary Hypothyroidism
JS
Secondary Hypothyroidism
Tertiary Hypothyroidism
IRA
SIR
18. HYPOTHYROIDISM
J
IRA
DIAGNOSIS
SIR
Serum TSH
RAJ
Above Normal Below Normal
IRI
Primary Hypothyroidism
JS Secondary Hypothyroidism
Tertiary Hypothyroidism
IRA
SIR
19. HYPOTHYROIDISM
J
IRA
Treatment
SIR
Thyroxin replacement
Goal:
RAJ
Primary hypothyroidism:
Normalized TSH
IRI
Secondary hypothyroidism:
JS
T4 in upper half of normal limit
IRA
SIR
20. HYPOTHYROIDISM
J
IRA
Treatment
SIR
Highly successful in bringing patients back
to normal metabolic state
RAJ
Therapy continues for life
Caution when commencing treatment
- risk of MI
IRI
JS
Patients observed for signs of
• Angina
IRA
• ECG changes
SIR
• Dyspnoea
• Palpitations
• Arrythmias
21. THYROTOXICOSIS
Excess of the thyroid hormone resulting
J
IRA
in an hypermetabolic state
Signs & Symptoms :-
SIR
Weight loss (but normal Generalised muscle
RAJ
appetite) weakness
Sweating; heat intolerance Diarrhoea
IRI
Fatigue JS Rapid bounding pulse
Palpitation; sinus Shortness of breath
tachycardia or atrial fibrilation Warm moist skin
IRA
Angina; Heart failure (high Insomnia
SIR
output)
Agitation; tremor
22. THYROTOXICOSIS
J
IRA
Hyperthyroidism Other causes of
thyrotoxicosis
SIR
-Graves’ disease -Subacute thyroiditis
RAJ
-Toxic multinodular goiter -Excessive iodine intake
-Thyrotoxicosis factitious
IRI
JS -Struma ovarii
Increase uptake Decrease uptake
IRA
SIR
Antithyroid drug Treat cause
+Ablative treatment
23. HYPERTHYROIDISM
J
IRA
Definition:-
SIR
"Excessive secretion of the thyroid hormone
resulting in an hypermetabolic state.....".
RAJ
IRI
Incidence:-
JS
2 - 5% of all females between age of 30-50 yrs
Male / female: 1 : 7
IRA
Can be precipitated by a life 'crisis'
SIR
24. HYPERTHYROIDISM
J
IRA
Aetiology
SIR
Primary (99%) Secondary (Rare)
RAJ
Thyroid Tissue Over Secretion
Disease by Pituitary Tumor
IRI
Autoimmune
Increased TSH
(Graves’ Disease) Thyroid nodule
JS Production
Thyroid Stimulating Antibodies (Toxic adenoma)
IRA
Increased Autonomous Increased Thyroxin
Stimulation of TSH Receptors Production
SIR
Increased Thyroxin
Production
25. Hyperthyroidism
J
IRA
Signs & Symptoms :-
SIR
Weight loss (but normal Generalised muscle
appetite) weakness
RAJ
Sweating; heat intolerance Diarrhoea
Rapid bounding pulse
IRI
Fatigue
Palpitation; sinus
JS Shortness of breath
tachycardia or atrial fibrilation Warm moist skin
Angina; Heart failure (high Insomnia
IRA
output)
SIR
Agitation; tremor
26. SIR
IRA
JS
IRI
RAJ
Thyroid Acropachy
SIR
IRA
J
28. Graves’ Disease - Eyes
J
IRA
SIR
RAJ
IRI
JS
IRA
SIR
Proptosis Exopthalmos
29. J
IRA
SIR
RAJ
IRI
JS
IRA
SIR
Periorbital Myxoedema
30. SIR
IRA
JS
IRI
RAJ
Pretibial Myxedema
SIR
IRA
J
31. HYPERTHYROIDISM
J
IRA
Diagnosis
SIR
Serum T3, T4 and free T3,T4
RAJ
Above Normal
IRI
Primary Hyperthyroidism
JS
Secondary Hyperthyroidism
IRA
SIR
32. HYPERTHYROIDISM
J
IRA
Diagnosis
SIR
Serum TSH
RAJ
Below Normal Above Normal
IRI
PrimaryJS Secondary
Hyperthyroidism Hyperthyroidism
IRA
SIR
33. HYPERTHYROIDISM
J
IRA
Treatment :-
SIR
Highly successful in bringing patients back to
RAJ
normal metabolic state
IRI
Long term follow-up
Treatment:
JS
Anti-Thyroid drugs
IRA
Radioiodine
SIR
Thyroidectomy
Partial
Total
34. HYPERTHYROIDISM
J
IRA
Treatment :-
SIR
Anti-Thyroid drugs
Dose:
RAJ
Start: PTU 150-300 mg/day or Methimazole 15-
IRI
30 mg/day
Maintain: taper dose as clinical and laboratory
JS
results
IRA
Duration: 1 ½ - 2 years
Side effects
SIR
Minor: Rash
Major: Agranulocytosis, hepatitis
35. HYPERTHYROIDISM
J
IRA
Treatment :-
SIR
Ablative treatment
Indication:
RAJ
Failure to medication
IRI
Relapse or recurrent
Major drug adverse reaction
JS
Patient with underlying heart disease
IRA
Toxic adenoma
Options:
SIR
Radioactive iodine
Surgery
40. Case 1
J
IRA
• 66 year old lady
SIR
• Presents with:
• Depression
RAJ
• Myalgia
IRI
• Weight gain
• On Examination:
JS
• Slow relaxing reflexes
IRA
• Sinus bradycardia
SIR
• BMI 32
• Swelling on the anterior aspect of the neck
42. Case 1
J
IRA
• What is the diagnosis?
SIR
RAJ
Hypothyroidism
IRI
JS
FT4 and TSH
IRA
Thyroid antibody
SIR
43. Case 2
J
IRA
• 36 year old lady
SIR
• Presents with:
•
RAJ
Weight loss
• Dyspnea on exertion For 6 months
•
IRI
Palpitation
JS
• On Examination:
IRA
• Diffuse thyroid enlargement
•
SIR
Sinus tachycardia, warm moist skin
• Exophthalmos
45. Case 2
J
IRA
• What is the diagnosis?
SIR
RAJ
Hyperthyroidism: Graves’ disease
IRI
JS
T3, T4 and TSH
IRA
SIR
46. Case 3
J
IRA
• 36 year old lady
SIR
• Presents with:
•
RAJ
Weight loss
• Dyspnea on exertion For 2 months
•
IRI
Palpitation
JS
• On Examination:
IRA
• Thyroid nodule 3 cm at leftt lobe
•
SIR
Sinus tachycardia, warm moist skin
• No exophthalmos, no pretibial myxedmea
48. Case 3
J
IRA
• What is the diagnosis?
SIR
RAJ
Thyrotoxicosis:
IRI
Toxic adenoma
JS
Exogenous thyroid
IRA
T3, T4 and TSH
SIR
Thyroid scan
49. Thyroid scan
J
IRA
SIR
RAJ
IRI
JS
IRA
SIR
Toxic adenoma
50. Topic
J
IRA
Thyroid disease
SIR
DM
RAJ
IRI
JS
IRA
SIR
51. Diagnostic criteria for diabetes
J
IRA
Venous Plasma Glucose
SIR
concentration, mg dl-1
Diabetes mellitus
RAJ
Fasting* ≥126
Symptom of DM + Casual plasma ≥200
IRI
Glucose JS
2-h post glucose load ≥200
IRA
*Repeat in different day
SIR
52. Classification of Diabetes
J
IRA
Type 1 Diabetes
SIR
Type 2 Diabetes
Gestational Diabetes
RAJ
Other types
IRI
– Endocrine disease
JS
– Chronic pancreatitis
IRA
– Malnutrition-related diabetes mellitus
(MRDM)
SIR
53. Case 1
J
IRA
39-year old woman came to
SIR
see you because polyuria,
polydipsia and nocturia 4
RAJ
times/night.
IRI
PE Diagnosis mmHg, other
BP 130/90 Diabetes
JS
as in figure
IRA
You ordered BG stat (11am)
and it was 230 mg/dl
SIR
Cause of Diabetes
Cushing’s syndrome
54. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
55. Conclusion:
The Modified Alphabet Strategy
J
IRA
SIR
• Advice Smoking , diet , exercise
• Blood pressure < 130/80
RAJ
• Cholesterol LDL ≤ 100
IRI
• Diabetes control
JS HbA1c ≤ 7%
• DN screening Annual examination
IRA
• Eye examination Annual examination
• Feet examination Annual examination
SIR
• Guardian drugs Aspirin, ACEI, statins
56. Case 2
J
IRA
Mr. M,46-yr old man came to you for check up
SIR
He had no underlying disease without any
symptoms of hyperglycemia
RAJ
Smoking and drinking occasionally
Type 2 diabetes, HT,
On physical examination, his blood pressure
IRI
Combined dyslipidemia,
was 130/90 mmHg and his BMI was 31 kg/m2,
Obesity
others were unremarkable
JS
His lab investigation were followed, FPG 155
IRA
mg/dl, CH 250 mg/dl, TG 200 mg/dl, HDL 40
mg/dl, LDL 170 mg/dl
SIR
1 week later, his FPG was 150 mg/dl, HbA1c
was 7.5%
57. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
58. Initiation of antihypertensive treatment
Other risk Normal High normal Grade 1 HT Grade 2 HT Grade 3 HT
factors, OD SBP 120-129 or SBP 130-139 SBP 140-159 or SBP 160-179 or SBP ≥180 or
or disease DBP 80-84 or DBP 85-89 DBP 90-99 DBP 100-109 DBP ≥110
J
IRA
Lifestyle Lifestyle
Lifestyle
changes for changes for
changes +
No other risk No BP No BP several months several weeks
immediate
SIR
factors intervention intervention then drug then drug
drug
treatment if BP treatment if BP treatment
uncontrolled uncontrolled
Lifestyle Lifestyle
RAJ
Lifestyle
changes for changes for
changes +
1-2 risk Lifestyle Lifestyle several weeks several weeks
factors changes changes immediate
then drug then drug
drug
IRI
treatment if BP treatment if BP treatment
uncontrolled uncontrolled
3 or more Lifestyle
JS
risk factors, Lifestyle changes and Lifestyle
MS, OD or changes consider drug Lifestyle Lifestyle changes +
diabetes treatment changes + drug changes + drug immediate
IRA
Lifestyle treatment treatment drug
Diabetes Lifestyle treatment
changes changes +
drug treatment
SIR
Lifestyle
Lifestyle Lifestyle Lifestyle Lifestyle
Established changes +
changes + changes + changes + changes +
CV or renal immediate
disease immediate drug immediate immediate drug immediate drug
treatment drug treatment treatment treatment drug
treatment
59. Antihypertensive Treatment: Preferred Drugs
General rules: lower SBP and DBP to goal. Use any effective agent at adequate doses, if useful in combination. Use long
J
acting agents to lower BP throughout 24 hours. Avoid or minimize adverse effects.
IRA
Subclinical organ damage
Left ventricular hypertrophy ACE inhibitors, calcium antagonists,
angiotensin receptor antagonists
SIR
Asymptomatic atherosclerosis Calcium antagonists, ACE inhibitors
Microalbuminuria ACE inhibitors, angiotensin receptor antagonists
Renal dysfunction ACE inhibitors, angiotensin receptor antagonists
RAJ
Clinical event
Previous stroke Any BP lowering agent
Previous MI β-blockers, ACE inhibitors, angiotensin receptor antagonists
Angina pectoris β-blockers, calcium antagonists
IRI
Heart failure diuretics, β-blockers, ACE inhibitors, angiotensin receptor
antagonists, antialdosterone agents
Atrial fibrillation
Recurrent ACE inhibitors, angiotensin receptor antagonists
Continuous
JS β-blockers, non-dihydropiridine calcium antagonists
Renal failure/proteinuria ACE inhibitors, angiotensin receptor antagonists, loop diuretics
Peripheral artery disease Calcium antagonists
IRA
Condition
Isolated systolic hypertension (elderly) Duretics, calcium antagonists
Metabolic syndrome ACE inhibitors, angiotensin receptor antagonists, calcium
antagonists
SIR
Diabetes mellitus ACE inhibitors, angiotensin receptor blocker
Pregnancy calcium antagonists, methyldopa, β-blockers
Blacks diuretics, calcium antagonists
60. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
61. NCEP ATP III: LDL-C Goals
(2004 Modifications)
J
IRA
High Risk Moderately Moderate Lower
High Risk Risk Risk
CHD or CHD risk ≥ 2 risk ≥ 2 risk < 2 risk
SIR
equivalents factors factors factors
190 (10-yr risk (10-yr risk (10-yr risk
>20%) 10-20%) <10%) goal
160
RAJ
mg/dL
160
LDL-C level
goal goal
IRI
130 130
mg/dL mg/dL
130 goal
JS
100
mg/dL
IRA
100
Existing LDL-C goals
SIR
Proposed LDL-C
goals
70 -
*CHD risk equivalents = DM, PAD, Stroke, CKD
Grundy SM et al. Circulation 2004;110:227-239.
62. Major Risk Factors
J
IRA
Cigarette smoking
SIR
HT: BP ≥140/90 mmHg or on antihypertensive agent
Low HDL-C (<40 mg/dL)†
RAJ
Family history of premature CHD
IRI
– CHD in male first degree relative <55 years
JS
– CHD in female first degree relative <65 years
Age (men ≥45 years; women ≥55 years)
IRA
SIR
† HDL-C ≥60 mg/dL counts as a “negative” risk factor
63. NCEP ATP III: 2004 Modifications
High Risk Moderately Moderate Lower
High Risk Risk Risk
J
CHD or CHD risk ≥ 2 risk ≥ 2 risk < 2 risk
IRA
equivalents factors factors factors
190 (10-yr risk (10-yr risk (10-yr risk
>20%) 10-20%) <10%) goal
SIR
160
mg/dL
160
LDL-C level
goal goal
RAJ
130 130
mg/dL mg/dL
130
IRI
goal
or
100 optional
mg/dL 100
mg/dL*
JS
100
or
Existing LDL-C goals
optional
70
IRA
Proposed LDL-C
mg/dL* goals
70 -
SIR
* And other clinical forms of atherosclerotic disease.
# very high risk category = established CVD plus multiple major risk factors
(especially diabetes), severe and poorly controlled risk factors (e.g. cigarette
smoking), metabolic syndrome (TG > 200 mg/dL + non-HDL-C >130 mg/dL with
HDL-C < 40 mg/dL]), and acute coronary syndromes.
64. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
65. Oral hypoglycemic drugs
J
IRA
Insulin secretagogue
SIR
– Sulfonylurea: glibenclamide, glipizide,
gliclazide
RAJ
– Glinide group
IRI
Biguanide: metformin
α-Glucosidase Inhibitor: acarbose,
JS
voglibose
IRA
Thiazolidinediones: Rosiglitazone,
SIR
plioglitazone
Incretin
66. Primary sites of action of oral
anti-diabetic agents
J
IRA
Biguanides
Thiazolidinediones
SIR
DPP-4
RAJ
inhibitors
IRI
DPP-4
Insulin
JS
Glucose
GLP-1
IRA
Sulphonylureas α-glucosidase inhibitors
SIR
GLP-1 and meglitinides
analogues
67. J
IRA
SIR
RAJ
IRI
JS
IRA
SIR
ITC-1. Annals of Int Med. 2007
68. Insulin
J
IRA
Intermediate acting: NPH, Humulin N,
SIR
Insulatard
Short acting: RI, Humulin R, Actrapid
RAJ
Premixed insulin: Humulin 70/30,
IRI
Mixtard 30
JS
Rapid acting: Insulin lispro, aspart
IRA
Long acting insulin: Insulin glargine,
determir
SIR
69. การออกฤทธิ์ของอินซูลิน
J
IRA
Aspart
Lispro
SIR
Regular
NPH
RAJ
Glargine
Detemir
IRI
JS
4 8 12 16 20 24
IRA
ระยะเวลาหลังฉีดยาอินซูลิน (ชั่วโมง)
SIR
70. ADA/EASD 2008 guideline
Tier 1: Well-validated core therapies
J
Lifestyle + metformin Lifestyle + metformin
IRA
+ +
At diagnosis basal insulin Intensify insulin
*HbA1c >8.5%
SIR
Lifestyle
modification +
metformin Lifestyle + metformin
+
RAJ
sulfonylurea
Step 1 Step 2 Step 3
IRI
Tier 2: Less Lifestyle + metformin Lifestyle + metformin
well-validated +
JS +
therapies Pioglitazone Pioglitazone
No hypoglycemia +
IRA
CHF, Bone loss sulfonylurea
Lifestyle + metformin
SIR
Lifestyle + metformin
+
+
GLP-1 agonist
basal insulin
No hypogly, Wt loss
Nausea vomitting
Nathan DM, et al. Diabetes care 2008; 31:1-11.
71. Thai’s guideline for management of T2DM
J
IRA
FPG <200 mg/dl or Lifestyle modification
HbA1c <8% 1-3 months
SIR
Insulin resistance Insulin defiiciency
phenotype phenotype
Monotherapy
Concurrent with medication
FPG 200-300 mg/dl
RAJ
Metformin or Sulfonylurea
Lifestyle modification
Other: TZDs, Glinide, AGI
IRI
or DPP-IV inhibitor
FPG 250-350 mg/dl or
HbA1c >9%
JS Combination OHA
IRA
FPG >300 mg/dl or
Insulin therapy
HbA1c >11% or
SIR
Symptomatic hyperglycemia Basal or Premixed or MDI
72. Approach to patient with poor
glycemic control
J
IRA
Diet history
SIR
Exercise history
RAJ
Compliance history
Concurrent medication
IRI
– Herbal medicine
JS
– Steroid
IRA
– Diuretics, beta-blocker
SIR
Occult infection
73. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
74. Screening for Diabetic
Nephropathy
J
IRA
SIR
Test When Normal Range
RAJ
Blood Each office visit <130/80 mm/Hg
1
Pressure
GFR = ([140-age] X weight in kg) X 0.85 (if female)
IRI
Creatinine Annually >90 ml/min per 1.73
Clearance1 JS m2 BSA
(serum creatinine X 72)
Urinary Type 2: Annually <30 mg/day
IRA
1
Albumin beginning at diagnosis <30 μg/mg creatinine
Type 1: Annually, 5 -years
SIR
post -diagnosis
1American Diabetes Association: Nephropathy in Diabetes (Position
Statement). Diabetes Care 27 (Suppl.1): S79-S83, 2007
75. Definitions of abnormalities in
albumin secretion
J
IRA
SIR
Category Spot collection
μg/mg creatinine
RAJ
Normal <30
IRI
Microalbuminuria 30-299
JS
IRA
Macroalbuminuria >300
SIR
1American Diabetes Association: Nephropathy in Diabetes (Position
Statement). Diabetes Care 28 (Suppl.1): S3-41, 2008
76. Stage of CKD
J
IRA
SIR
Stage GFR
ml/min per 1.73m2 BSA
RAJ
1 >90
IRI
2 60-89
3 30-59
JS
4 15-29
IRA
5 <15 or dialysis
SIR
1American Diabetes Association: Nephropathy in Diabetes (Position
Statement). Diabetes Care 28 (Suppl.1): S3-41, 2008
77. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
78. Diabetic foot
J
IRA
Inspection:
SIR
– Deformity
– Dryness or cracks in
RAJ
the skin
– Wound
IRI – Gangrene
JS
– Callus
IRA
– Toe nail
SIR
Hallux valgus
79. Diabetic foot
J
IRA
SIR
Pulse
– Dorsalis pedis pulse
RAJ
– Posterior tibial pulse
–
IRI
Popliteal
– Femoral
JS
IRA
SIR
80. Diabetic foot
J
IRA
Monofilament
– โดยใหผูปวยหลับตา กดปลาย
SIR
monofilament ที่แขนผูปวยกอน
เพื่อใหผูปวยรูวาจะรูสึกอยางไร
RAJ
– ใหผูปวยหลับตา กดปลาย
IRI
monofilament ใหตั้งฉากกับฝาเทา
ให monofilament โคงงอเล็กนอย
JS
ประมาณ 1-1.5 วินาที
IRA
Loss of protective sense ==จากการตรวจ10 จุด ดังรูป โดยตรวจ
Loss of protective sense ตรวจครบ monofilament ผูปววยไม
– จากการตรวจ monofilament ผูป ยไม
รูรูสึกถึงแรงกดมากกวา44จุจุดในา10จุจุดทีตรวจ ครั้ง (ถาตอบถูก 2 ใน 3
สึกถึงแรงกดมากกวา ดใน 10 ดทีง่ละ 3
ตํ แหน ตรวจ
SIR
่
ครั้ง = OK)
– ถามวาผูปวยรูสกหรือไม
ึ
82. Advice foot care
J
IRA
Daily feet inspection, including areas between the
toes
SIR
If vision is impaired, people with diabetes should not
attempt their own foot care
RAJ
Regular washing of feet with careful drying, especially
between the toes
IRI
Water temperature – always below 37C
Do not use a heater or a hot-water bottle to warm
JS
your feet
IRA
Use of lubricating oils or creams for dry skin - but not
between the toes
SIR
83. Advice foot care
J
IRA
Avoidance of barefoot walking indoors or
outdoors and of wearing of shoes without
SIR
socks
Daily inspection and palpation of the inside of
RAJ
the shoes
Do not wear tight shoes or shoes with rough
IRI
edges
Daily change of socks
JS
Wearing of stocking with seams inside out or
IRA
preferably without any seams
Never wear tight or knee-high socks
SIR
84. Advice foot care
J
IRA
Cutting nails straight across
SIR
Chemical agents or plasters to
remove corns and calluses - should
not be used
RAJ
Corns and calluses - should be cut
IRI
by a healthcare provider
Patient awareness of the need to
JS
ensure that feet are examined
IRA
regularly by a healthcare provider
Notifying the healthcare provider at
SIR
once if a blister, cut, scratch or sore
has developed
85. Conclusion
J
IRA
What type of diabetes he/she has?
SIR
What is the goal for this patient?
We should correct and take care everything
RAJ
according to alphabet strategy
Which medication suitable for this patient?
IRI
According to guideline
JS
Does she/he have any contra-indication for this
IRA
medication?
Lifestyle modification is the fundamental
SIR
management of diabetes
86. Diabetes Care:
J
THE ALPHABET STRATEGY
IRA
SIR
Advice
RAJ
Blood pressure
Cholesterol
IRI
Diabetes Control
JS
Alphabet DN screening
Eye Examination
Strategy
IRA
Feet Care
Guardian Drugs
SIR
87. Topic
J
IRA
Thyroid disease
SIR
DM
RAJ
Endocrine emergency
IRI
JS
IRA
SIR